Truist Securities Reiterates Buy Rating on Sabra Health Care REIT, Inc. (SBRA)

Market Context

Sabra Health Care REIT, Inc. operates in the Real Estate sector. The stock currently trades at $21.98 with a market capitalization of $4.5B.

Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sabra Health Care REIT, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Sabra Health Care REIT, Inc.

Among the 10 most recent ratings: 4 Buy, 5 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 22, 2026	Citizens	Market Outperform	N/A
Jul 22, 2026	Truist Securities	Buy	N/A
Jul 22, 2026	Baird	Neutral	N/A
Jul 08, 2026	Truist Securities	Buy	N/A
Jul 08, 2026	UBS	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View SBRA Stock Page